Show simple item record

dc.contributor.authorCarter, Jane
dc.date.accessioned2025-02-26T06:19:28Z
dc.date.available2025-02-26T06:19:28Z
dc.date.issued2021-03-07
dc.identifier.citationVieri MK, Hotterbeekx A, Raimon S, Abd-Elfarag G, Mukendi D, Carter JY, Kumar-Singh S, Colebunders R. Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature. Pathogens. 2021 Mar 7;10(3):310. doi: 10.3390/pathogens10030310. PMID: 33799934; PMCID: PMC7998365.en_US
dc.identifier.urihttps://repository.amref.ac.ke/handle/20.500.14173/965
dc.description.abstractNeuro-inflammation may be associated with onchocerciasis-associated epilepsy (OAE) but thus far very few immunological studies have been performed in children with this form of epilepsy. In a pilot study we measured the cytokine levels in cerebrospinal fluid (CSF) of persons with OAE from Maridi, South Sudan, and from Mosango, Democratic Republic of the Congo (DRC) and compared these results with cytokine levels in CSF of Africans with non-OAE neurological disorders, and Europeans with epilepsy or other neurological conditions. The following cytokines were studied: IL-6, TNF-α, IL1-β, IL-5, IL-4, IL-13, CCL3 (Mip-1α), VEGF-C, VCAM-1. No cytokine was significantly associated with OAE, although a lower IL-13 level was observed in CSF of persons with OAE compared to African controls. Observed cytokine profiles and neuro-inflammation may be the consequence of long-standing epilepsy, concomitant infections and malnutrition. Ideally cytokine levels should be determined in a prospective study in serum and CSF collected at the time of onset of the first seizures.en_US
dc.language.isoenen_US
dc.publisherPathogensen_US
dc.subjectcerebrospinal fluid; cytokines; onchocerciasis-associated epilepsy.en_US
dc.titleCytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literatureen_US
dc.typeArticle, Journalen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record